Tradewinds Capital Management, LLC Incyte Corp Transaction History

Tradewinds Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	BUY	$51.18 - $63.75 $1,279 - $1,593	25 New	25 $1,000
Q4 2021 Feb 02, 2022	SELL	$63.34 - $74.11 $12,668 - $14,822	-200 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$74.18 - $108.93 $593 - $871	-8 Reduced 3.85%	200 $21,000
Q1 2020 May 11, 2020	BUY	$63.18 - $85.97 $505 - $687	8 Added 4.0%	208 $15,000
Q4 2017 Feb 01, 2018	BUY	$93.56 - $116.6 $18,712 - $23,320	200	200 $19,000

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Tradewinds Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Tradewinds Capital Management, LLC with notifications on news.